Search for: "Mylan Pharmaceuticals"
Results 621 - 640
of 739
Sorted by Relevance
|
Sort by Date
23 Mar 2018, 10:54 am
Mylan Inc. [read post]
12 Apr 2011, 10:07 pm
Infringement proceedings by the European Commission against Italy (Kluwer Patent Blog) India approves free access to important portions of the Traditional Knowledge Digital Library (TK Community) (Spicy IP) USPTO proposes changes to PTA and PTE provisions (Patent Docs) US: FDA issues warning letter for failure to submit animal study reports in an IDE (FDA Law Blog) US: AMP v USPTO – oral argument at the Federal Circuit (Patent Docs) US: A historical perspective on the gene patent controversy… [read post]
15 Feb 2011, 5:26 pm
(FDA Law Blog) Diovan (Vasartan) – France: Novartis v Actavis – preliminary injunction for Valsartan confirmed (The SPC Blog) Diovan HTC (Valsartan) – Belgium: Antwerp Court of Appeal stops infringement of Valsartan/HCTZ SPC based on patent claiming Valsartan alone: Novartis v Teva (The SPC Blog) Lescol (Fluvastatin) – US: Novartis files patent infringement complaint against Mylan following Para IV challenge (Patent Docs) (GenericsWeb) Mucinex (Guaifenesin) –… [read post]
15 Sep 2010, 2:40 am
(Afro-IP) Africa: Giving consumers power in the battle against counterfeits (Afro-IP) Australia: Review Four Corners’ ‘Body Corporate’ program on gene patenting (Patentology) India: Roche and Novartis, finally, manage to defend their patents in oppositions filed by Cipla (Spicy IP) South Africa: San people push for new legislation – demand protection for indigenous knowledge and IP including medicinal remedies derived from plants including Hoodia (Afro-IP) US: PHOSITA:… [read post]
5 Oct 2020, 10:25 am
Mylan Pharmaceuticals Inc., No. 19-1451; Arthrex, Inc. v. [read post]
3 Jan 2018, 5:10 am
On the heels of the Ericsson decision, further briefing on the waiver issue was recently authorized in Mylan Pharmaceuticals Inc., et al. v. [read post]
15 Jul 2008, 4:33 pm
We start with the recent allegations being made against the Indian pharmaceutical giant Ranbaxy Laboratories, which manufactures drugs at 11 sites around the globe and had global sales of $1.6 billion last year. [read post]
23 Mar 2018, 10:54 am
Mylan Inc. [read post]
6 Mar 2014, 12:41 pm
Thus FDA-approved statements have been exempted from consumer protection/fraud liability:The pharmaceutical industry is highly regulated, both at the federal level and internationally. [read post]
2 Mar 2012, 6:52 am
PARISIAN TRANSCRIPTS 2.0 We had a number of people send us material after our first post with out list of deposition transcripts (and various other items) concerning the testimony of the extremely active plaintiffs’ side expert, Dr. [read post]
9 Aug 2012, 5:00 am
Nittany Pharmaceuticals (?) [read post]
28 Oct 2009, 6:15 am
(The SPC Blog) EU: European Federation of Pharmaceutical Industries and Associations unveils anti-counterfeit authentication system (IP Watch) US: Time Magazine on data exclusivity debate (Patent Docs) US: BIO's IPCC Conference: Behind the scenes look at patent cases - Mayo v Prometheus; Bilski v Doll; Laboratory Court of Am. [read post]
3 Oct 2018, 8:51 am
Mylan Pharmaceuticals). [read post]
7 Mar 2022, 2:07 pm
In 2017, Mylan paid $465 million for misclassifying EpiPen® as a generic drug to avoid paying the higher rebates owed on brand name drugs. [read post]
28 Oct 2009, 6:15 am
(The SPC Blog) EU: European Federation of Pharmaceutical Industries and Associations unveils anti-counterfeit authentication system (IP Watch) US: Time Magazine on data exclusivity debate (Patent Docs) US: BIO's IPCC Conference: Behind the scenes look at patent cases - Mayo v Prometheus; Bilski v Doll; Laboratory Court of Am. [read post]
10 Nov 2010, 1:11 am
Roche (Filewrapper) (Property, intangible) US: Senator Sanders letter to FDA: U.S. needs an ethical pathway for biological products (KEI) (FDA Law Blog) US: Daiichi Sankyo seeks review and correction of patent term adjustment calculation for patent relating to ‘nucleoside and oligonucleotide analogues’ (Patent Docs) US: CAFC in Abraxis v Navinta: remembering Stanford/Roche (IPBiz) Products Alimta (Pemetrexed) – US: Eli Lilly files patent infringement complaint against Teva in… [read post]
28 Oct 2009, 7:15 am
(The SPC Blog) EU: European Federation of Pharmaceutical Industries and Associations unveils anti-counterfeit authentication system (IP Watch) US: Time Magazine on data exclusivity debate (Patent Docs) US: BIO’s IPCC Conference: Behind the scenes look at patent cases – Mayo v Prometheus; Bilski v Doll; Laboratory Court of Am. [read post]
6 Jul 2011, 2:21 am
(2) (PatLit) Lidoderm (Lidocaine) – US: Delaware District Court decision in Endo Pharmaceuticals patent case favors Watson (GenericsWeb) Lidoderm (Lidocaine) – US: Endo files patent infringement suit against Watson in response to Para IV challenge (Patent Docs) Lipitor (Atorvastatin) – UK: English Patent Court grants temporary restraining order against Teva on short notice – Pfizer threatens pharmacies with legal action over generic Atorvastatin supply (Kluwer Patent… [read post]
15 Jun 2007, 8:11 am
Mylan Laboratories, Inc., et al., and Ormco Corporation, et al. v. [read post]
24 Sep 2010, 1:15 pm
Mylan Labs, Inc., 520 F.3d 1358 (Fed. [read post]
